Riham Abouleisa

ORCID: 0000-0001-8883-068X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tissue Engineering and Regenerative Medicine
  • Congenital heart defects research
  • Cardiac Fibrosis and Remodeling
  • Cardiovascular Function and Risk Factors
  • 3D Printing in Biomedical Research
  • Cardiac electrophysiology and arrhythmias
  • CRISPR and Genetic Engineering
  • Signaling Pathways in Disease
  • Mitochondrial Function and Pathology
  • Cardiomyopathy and Myosin Studies
  • Pluripotent Stem Cells Research
  • ATP Synthase and ATPases Research
  • Electrospun Nanofibers in Biomedical Applications
  • Pancreatic function and diabetes
  • RNA modifications and cancer
  • Ion channel regulation and function
  • Virus-based gene therapy research
  • Viral Infections and Immunology Research
  • Endoplasmic Reticulum Stress and Disease
  • Autophagy in Disease and Therapy
  • Protein Degradation and Inhibitors
  • Hippo pathway signaling and YAP/TAZ
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Kruppel-like factors research
  • Fibroblast Growth Factor Research

University of Louisville
2019-2025

Baylor College of Medicine
2024-2025

Louisville Institute
2022-2023

University of Louisville Hospital
2020-2022

University of Manchester
2010-2016

Manchester Academic Health Science Centre
2011-2014

Preclinical testing of cardiotoxicity and efficacy novel heart failure therapies faces a major limitation: the lack an in situ culture system that emulates complexity human tissue maintains viability functionality for prolonged time. To develop reliable, easily reproducible, medium-throughput method to pig slices under physiological conditions period Here, we describe novel, biomimetic (300 µm thickness) 6 days culture. We optimized medium with continuous electrical stimulation at 1.2 Hz...

10.1161/circresaha.119.314996 article EN Circulation Research 2019-07-16

The regenerative capacity of the heart after myocardial infarction is limited. Our previous study showed that ectopic introduction 4 cell cycle factors (4F; CDK1 [cyclin-dependent kinase 1], CDK4 4], CCNB [cyclin B1], and CCND D1]) promotes cardiomyocyte proliferation in 15% to 20% infected cardiomyocytes vitro vivo improves cardiac function mice.

10.1161/circulationaha.121.057641 article EN Circulation 2022-01-21

Identification of the signaling pathways that regulate cyclic nucleotide microdomains is essential to our understanding cardiac physiology and pathophysiology. Although there growing evidence plasma membrane Ca(2+)/calmodulin-dependent ATPase 4 (PMCA4) a regulator neuronal nitric-oxide synthase, physiological consequence this regulation unclear. We therefore tested hypothesis PMCA4 has key structural role in tethering synthase highly compartmentalized domain cell membrane. This functional...

10.1074/jbc.m111.290411 article EN cc-by Journal of Biological Chemistry 2011-10-01

Abstract The heart responds to pathological overload through myocyte hypertrophy. Here we show that this response is regulated by cardiac fibroblasts via a paracrine mechanism involving plasma membrane calcium ATPase 4 (PMCA4). Pmca4 deletion in mice, both systemically and specifically fibroblasts, reduces the hypertrophic pressure overload; however, knocking out cardiomyocytes does not produce effect. Mechanistically, lacking PMCA4 higher levels of secreted frizzled related protein 2...

10.1038/ncomms11074 article EN cc-by Nature Communications 2016-03-29

The adult mammalian heart is recalcitrant to regeneration after injury, in part due the postmitotic nature of cardiomyocytes. Accumulating evidence suggests that cardiomyocyte proliferation fetal or neonatal mammals and regenerative non-mammalian models depends on a conducive metabolic state. Results from numerous studies hearts indicate conditions relatively low fatty acid oxidation, reactive oxygen species generation, high glycolysis are required for induction proliferation. Glycolysis...

10.1093/stmcls/sxac016 article EN cc-by-nc Stem Cells 2022-03-05

Obesity-induced lipid overload in cardiomyocytes contributes to profound oxidative stress and cardiomyopathy, culminating heart failure. In this study, we investigate a novel mechanism whereby lipids accumulate cardiomyocytes, seek the relevant treatment strategies. P21-activated kinase 3 (PAK3) was elevated obese human myocardium, murine hearts upon diet- or fatty acid–induced stress, respectively. Mice with cardiac-specific overexpression of PAK3 were more susceptible development cardiac...

10.2337/db24-0240 article EN Diabetes 2024-08-13

Cardiomyocytes (CMs) lost during ischemic cardiac injury cannot be replaced due to their limited proliferative capacity. Calcium is an important signal transducer that regulates key cellular processes, but its role in regulating CM proliferation incompletely understood. Here we show a robust pathway for new calcium signaling-based regenerative strategies. A drug screen targeting proteins involved cycling human embryonic stem cell-derived organoids (hCOs) revealed only the inhibition of...

10.1038/s41536-025-00389-z article EN cc-by-nc-nd npj Regenerative Medicine 2025-01-11

BACKGROUND: Morbidity and mortality of heart failure with preserved ejection fraction (HFpEF) is increased in metabolic disorders. However, options for preventing treating these prevalent outcomes are limited. Intramyocardial lipotoxicity contributes to cardiac dysfunction. Here, we investigate the mechanisms underlying endoplasmic reticulum degradation enhancing EDEM2 (endoplasmic degradation–enhancing alpha-mannosidase–like protein 2) regulation lipid homeostasis assess strategies that...

10.1161/circulationaha.124.072194 article EN cc-by Circulation 2025-03-25

The coordinated gene and metabolic programs that facilitate cardiomyocyte entry progression in the cell cycle are poorly understood. purpose of this study was to identify changes influence myocyte proliferation.In adult mouse cardiomyocytes human induced pluripotent stem (hiPS-CMs), initiation by ectopic expression Cyclin B1, D1, CDK1, CDK4 (termed 4F) downregulated oxidative phosphorylation genes upregulated regulate ancillary biosynthetic pathways glucose metabolism. Results from analyses...

10.1016/j.redox.2021.102094 article EN cc-by-nc-nd Redox Biology 2021-08-05

Abstract There is need for a reliable in vitro system that can accurately replicate the cardiac physiological environment drug testing. The limited availability of human heart tissue culture systems has led to inaccurate interpretations cardiac-related effects. Here, we developed c ardiac t issue ulture m odel (CTCM) electro-mechanically stimulate slices with stretches systole and diastole during cycle. After 12 days culture, this approach partially improved viability but did not completely...

10.1038/s42003-022-03919-3 article EN cc-by Communications Biology 2022-09-09

Diabetes is a metabolic disorder with an increased risk of developing heart failure. Inflammation and damaged vasculature are the cardinal features diabetes-induced cardiac damage. Moreover, systemic stress triggers discordant intercellular communication, thus culminating in dysfunction. Fibroblast growth factor 21 (FGF21) pleiotropic hormone transducing cellular signals via fibroblast receptor 1 (FGFR1) its co-receptor beta-klotho (β-KL). This study first demonstrated decreased expression...

10.1016/j.heliyon.2023.e14952 article EN cc-by-nc-nd Heliyon 2023-03-30

Myocardial inflammation contributes to cardiomyopathy in diabetic patients through incompletely defined underlying mechanisms. In both human and time-course experimental samples, hearts exhibited abnormal ER, with a maladaptive shift over time rodents. Furthermore, as cardiac ER dysfunction model, mice cardiac-specific p21-activated kinase 2 (PAK2) deletion heightened myocardial inflammatory response diabetes. Mechanistically, stress-induced CCAAT/enhancer-binding protein homologous (CHOP)...

10.1016/j.isci.2022.103973 article EN cc-by iScience 2022-02-23

Many novel drugs fail in clinical studies due to cardiotoxic side effects as the currently available vitro assays and vivo animal models poorly predict human cardiac liabilities, posing a multi-billion-dollar burden on pharmaceutical industry. Hence, there is worldwide unmet medical need for better approaches identify drug cardiotoxicity before undertaking costly time consuming 'first man' trials. Currently, only immature cells (human induced pluripotent stem cell-derived cardiomyocytes...

10.3791/60913 article EN Journal of Visualized Experiments 2020-03-20

Abstract Aims Gene therapies to induce cardiomyocyte (CM) cell cycle re-entry have shown a potential treat subacute ischaemic heart failure (IHF) but not been tested in the more relevant setting of chronic IHF. Our group recently showed that polycistronic non-integrating lentivirus encoding Cdk1/CyclinB1 and Cdk4/CyclinD1 (TNNT2-4Fpolycistronic-NIL) is effective inducing CM ameliorating IHF models preventing subsequent IHF-induced congestions liver, kidneys, lungs rats pigs. Here, we aim...

10.1093/cvr/cvae002 article EN public-domain Cardiovascular Research 2024-01-01

Despite the development of clinical treatments, heart failure remains leading cause mortality. We observed that p21-activated kinase 3 (PAK3) was augmented in failing human and mouse hearts. Furthermore, mice with cardiac-specific PAK3 overexpression exhibited exacerbated pathological remodeling deteriorated cardiac function. Myocardium displayed hypertrophic growth, excessive fibrosis, aggravated apoptosis following isoprenaline stimulation as early two days. Mechanistically, using cultured...

10.1016/j.isci.2023.106970 article EN cc-by-nc-nd iScience 2023-05-27

Tumour necrosis factor-α (TNF-α) plays a key role in the regulation of cardiac contractility. Although cardiomyocytes are known to express TNF-α receptors (TNFRs), mechanism signal transmission is incompletely understood. The aim this study was investigate whether tumour suppressor Ras-association domain family protein 1 isoform A (RASSF1A) modulates signalling cardiomyocytes.We used RASSF1A knockout (RASSF1A(-/-)) mice and wild-type (WT) littermates study. Acute stimulation with low dose...

10.1093/cvr/cvu111 article EN cc-by Cardiovascular Research 2014-04-28

Abstract Background and Purpose Myocardial infarction (MI) is the leading cause of mortality globally due in part to limited ability cardiomyocytes (CMs) regenerate. Recently, we demonstrated that overexpression four‐cell cycle factors, CDK1, CDK4, cyclin B1 D1 (4F), induced cell division ~20% post‐mitotic CMs overexpressed 4F. The current study aims identify a small molecule augments 4F‐induced CM induction. Experimental Approach, Key Results Screening molecules with potential augment...

10.1111/bph.16209 article EN British Journal of Pharmacology 2023-08-07

Many novel drugs fail in clinical studies due to cardiotoxic side effects as the currently available vitro assays and vivo animal models poorly predict human cardiac liabilities, posing a multi-billion-dollar burden on pharmaceutical industry. Hence, there is worldwide unmet medical need for better approaches identify drug cardiotoxicity before undertaking costly time consuming 'first man' trials. Currently, only immature cells (human induced pluripotent stem cell-derived cardiomyocytes...

10.3791/60913-v article EN Journal of Visualized Experiments 2020-03-20

Abstract The limited availability of human heart tissue and its complex cell composition are major limiting factors for reliable testing drug efficacy, toxicity understanding mechanism. Recently, we developed a functional pig slice biomimetic culture system that fully preserves the viability functionality 300 µm slices 6 days. Here, tested reliability this in delineating mechanisms known anti-cancer drugs cause cardiomyopathy. We three (doxorubicin, trastuzumab, sunitinib) associated with...

10.1101/2020.06.12.148197 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-06-13
Coming Soon ...